| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $6,158,587 ) (Continued on the next page) |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131104 | Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular disease | 000 | 5 | NIH | 12/23/2025 | $490,258 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $17,925 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $56,277 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $80,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 3 | NIH | 12/29/2025 | $616,459 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK141801 | Liver and kidney responses to bilirubin as a nuclear receptor hormone | 000 | 2 | NIH | 12/10/2025 | $380,625 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 21 | NIH | 12/9/2025 | $1,385,340 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA289528 | Molecular Mediators of Cell-free DNA biogenesis | 000 | 2 | NIH | 12/11/2025 | $603,132 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 000 | 1 | NIH | 12/30/2025 | $734,957 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 001 | 1 | NIH | 12/19/2025 | $2,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 001 | 3 | NIH | 12/26/2025 | $120,128 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 000 | 3 | NIH | 12/18/2025 | $181,255 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA249863 | Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data | 000 | 5 | NIH | 11/24/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA237895 | Time-dependent and bidirectional effect of oxidative stress - a missing piece of the free radical theory of cancer and its potential implications | 000 | 6 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR080629 | Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies | 000 | 4 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG090523 | The Effect of Serum Psychotropic Drug Levels and Drug Metabolizer Status on Delirium Duration and Long-term Cognition | 000 | 1 | NIH | 11/19/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI077505 | Pharmacogenomics of HIV Therapy | 000 | 16 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HL151871 | The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08HL175235 | Hypoxia-inducible factor(HIF)-driven modulation of alveolar regeneration | 000 | 1 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K01EB032898 | Microstructure and connectivity modeling from the cortex to the spinal cord in Multiple Sclerosis | 000 | 4 | NIH | 12/1/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43CA270474 | Vanderbilt-Zambia Cancer Research Training Program (VZCARE) | 000 | 4 | NIH | 11/21/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43CA270474 | Vanderbilt-Zambia Cancer Research Training Program (VZCARE) | 001 | 4 | NIH | 11/21/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | 90DDUC0153 | Vanderbilt Kennedy Center for Excellence in Developmental Disabilities | 01 | 1 | ACL | 12/28/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | TR753203 | Regional AIDS Education and Training Centers Program | 03 | 2 | HRSA | 12/8/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 21 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01CA262678 | Searching the blood metabolome to identify risk biomarkers for biliary tract cancer | 000 | 4 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24TR004432 | Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | 000 | 3 | NIH | 11/18/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24OD035523 | ECHO Laboratory Core at Vanderbilt for Integrated Sample Biobanking and Processing | 000 | 3 | NIH | 12/16/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01HL156620 | Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01DD001235 | Comp B National Spina Bifida Patient Registry at Vanderbilt Children's Hospital Component | 04 | 5 | CDC | 11/17/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01DD001234 | Comp C Spina Bifida Urologic Protocol at Vanderbilt Children's Hospital | 03 | 5 | CDC | 11/17/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R33MH122464 | Nicotinic Modulation of the Cognitive Control System in Late-Life Depression | 000 | 5 | NIH | 10/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | RF1AG075341 | Neuroinflammatory mechanisms underlying sepsis-induced cognitive dysfunction | 000 | 2 | NIH | 11/22/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R21DE033851 | Human Craniosynostosis Atlas (HuCA) : Standardizing & Establishing a Public Repository for Genomic and Imaging data | 000 | 2 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH127018 | Negative Valence Systems in Schizophrenia | 000 | 5 | NIH | 11/17/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH135028 | Ultra-high resolution imaging of category-selective visual cortex in autism | 000 | 2 | NIH | 12/23/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL173523 | Understanding Racial/Ethnic Disparities in Clinician Concordance with Hypertension Treatment Guidelines and Blood Pressure Control | 000 | 2 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL155207 | Biomarkers of ischemic brain injury in adults with sickle cell disease | 000 | 4 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK141523 | Comparing Placebo versus Antibiotics for Acute Uncomplicated Diverticulitis | 000 | 1 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK137997 | Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK139322 | Optimizing Stage 2 T1DM Management: Assessing the Impact of GLP-1Ra on Metabolic Outcomes in Patients Receiving Teplizumab | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK118407 | Phase 2 Study of Theophylline for the Treatment of Psuedohypoparathyroidism | 000 | 5 | NIH | 10/7/2025 | $0 |
|
